The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I open label study evaluating VT1021 in patients with advanced solid tumors.
 
Michael Cieslewicz
Employment - Vigeo Therapeutics
Stock and Other Ownership Interests - Vigeo Therapeutics
 
Devalingam Mahalingam
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; EMD Serono
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EMD Serono
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Genentech
Research Funding - Merck; Oncolytics
Expert Testimony - Blake Jones Law Firm
 
Wael A. Harb
Research Funding - AI Therapeutics
 
Amita Patnaik
Consulting or Advisory Role - Bayer; Genentech/Roche (I); Merck; Novartis
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Infinity Pharmaceuticals (Inst); Klus Pharma (Inst); Lilly (Inst); Livzon (Inst); Merck (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Plexxikon (Inst); Proximagen (Inst); Surface Oncology (Inst); Symphogen (Inst); Syndax (Inst); Tesaro (Inst); Vigeo Therapeutics (Inst)
 
Joyce F. Liu
Consulting or Advisory Role - Clovis Oncology; Mersana; Tesaro
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Regeneron (Inst); Surface Oncology (Inst); Tesaro (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; Novartis
Research Funding - Eisai; EMD Serono; Genentech; Novartis; Placon; Takeda
 
Andrea J. Bullock
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Medtronic
Consulting or Advisory Role - Bayer; Celgene; Exelixis; Halozyme; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Halozyme
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - AstraZeneca; Biosynergies; Merck; Merrimack; novarock
Research Funding - Amgen; Bristol-Myers Squibb; Gradalis; Halozyme; ITeos Therapeutics; Merck
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - AstraZeneca
 
Manish R. Patel
Consulting or Advisory Role - Pfizer/EMD Serono; Pharmacyclics/Janssen
Speakers' Bureau - Celgene; Exelixis; Genentech/Roche; Taiho Pharmaceutical
 
Robert Guttendorf
Consulting or Advisory Role - Vigeo Therapeutics
 
Suming Wang
Employment - ALKERMES (I); VIGEO THERAPEUTICS
Stock and Other Ownership Interests - ALKERMES (I); VIGEO THERAPEUTICS
 
Kathy Kerstein
Employment - Tetraphase Pharma; Vigeo Therapeutics
 
Gregory Ivan Berk
No Relationships to Disclose
 
Jing Watnick
Employment - Vigeo Therapeutics
Leadership - Vigeo Therapeutics
Stock and Other Ownership Interests - Vigeo Therapeutics
Consulting or Advisory Role - Vigeo Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Boston Children's Hospital (I)